|
46 Companies |
|
12 Products |
|
12 Products |
|
17 Mechanisms of Action |
|
756 Trials |
|
22406 News |
|
| «12...390391392393394395396397398399400401402» |
- Trial completion: Leucine Co-ingestion and Myofibrillar Protein Synthesis in Older Adults (clinicaltrials.gov) - Mar 16, 2016
P=N/A, N=20, Completed, Sponsor: McMaster University
Recruiting --> Completed
- | Enrollment open, Trial initiation date, Trial primary completion date: SPRINTT: Multicomponent Intervention for Physical Frailty and Sarcopenia (clinicaltrials.gov) - Mar 15, 2016
P3, N=1500, Recruiting, Sponsor: Catholic University of the Sacred Heart
Recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: Oct 2015 --> Jan 2016 | Trial primary completion date: Sep 2018 --> Dec 2018
- || Trial primary completion date: Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2 (clinicaltrials.gov) - Mar 10, 2016
P1, N=160, Recruiting, Sponsor: Metabolic Technologies Inc.
Not yet recruiting --> Recruiting | Initiation date: Oct 2015 --> Jan 2016 | Trial primary completion date: Sep 2018 --> Dec 2018 Trial primary completion date: Feb 2016 --> Dec 2017
- | New P4 trial: Effects of Supplementation of Vitamin D in Patients With Crohn's Disease (clinicaltrials.gov) - Mar 10, 2016
P4, N=130, Not yet recruiting, Sponsor: Federal University of Juiz de Fora
- NN1213 / Novo Nordisk
Enrollment change: Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. (clinicaltrials.gov) - Mar 9, 2016
P2, N=44, Completed, Sponsor: National Institute on Aging (NIA)
Trial primary completion date: Feb 2016 --> Dec 2017 N=75 --> 44
- || bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
Trial primary completion date: A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study (clinicaltrials.gov) - Mar 8, 2016
P2, N=240, Recruiting, Sponsor: Novartis Pharmaceuticals
N=75 --> 44 Trial primary completion date: Feb 2017 --> Feb 2018
- New trial: Effects of Power-velocity Muscle Characteristics During Ageing (clinicaltrials.gov) - Feb 26, 2016
P=N/A, N=80, Not yet recruiting, Sponsor: Universitaire Ziekenhuizen Leuven
- || New P2/3 trial: Carnitine Supplementation and Skeletal Muscle Function (clinicaltrials.gov) - Feb 26, 2016
P2/3, N=80, Recruiting, Sponsor: Gdansk University of Physical Education and Sport
- New P4 trial: Body Composition Measurements in Chronic Heart Failure (clinicaltrials.gov) - Feb 22, 2016
P4, N=35, Recruiting, Sponsor: Hungarian Institute of Cardiology
- New trial: Sarcopenia, Obesity, and Resistance Training (clinicaltrials.gov) - Feb 12, 2016
P=N/A, N=244, Recruiting, Sponsor: University of Brasilia
- Enrollment closed, Trial primary completion date: Preventive Physiotherapy Intervention in Elderly People With Sarcopenia (clinicaltrials.gov) - Feb 10, 2016
P=N/A, N=70, Active, not recruiting, Sponsor: University of Valencia
Trial primary completion date: Feb 2017 --> Feb 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Mar 2016
- New P2 trial: PSSMAR: Postacute Sarcopenia: Supplementation With ?-hydroxyMethylbutyrate After Resistance Training (clinicaltrials.gov) - Feb 10, 2016
P2, N=40, Not yet recruiting, Sponsor: Parc de Salut Mar
- Trial completion: PREFISSARC: Prevalence and Pathophysiology of Sarcopenia in the Elderly Patient With Hip Fracture (clinicaltrials.gov) - Feb 5, 2016
P=N/A, N=198, Completed, Sponsor: Hospital Viamed Valvanera, Spain
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Mar 2016 Active, not recruiting --> Completed
- Trial completion: HIPERPROT: Hyperprotein Nutritional Intervention in Elderly Patients With Hip Fracture and Sarcopenia (clinicaltrials.gov) - Feb 5, 2016
P=N/A, N=110, Completed, Sponsor: Hospital Viamed Valvanera, Spain
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Effects of Increased, Egg-Based Protein Intake on Muscle Composition, (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=22, Completed, Sponsor: Purdue University
Active, not recruiting --> Completed N=51 --> 22
- ||| Avastin (bevacizumab) / Roche
New trial, IO biomarker: A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With Bevacizumab (clinicaltrials.gov) - Feb 4, 2016
P=N/A, N=200, Not yet recruiting, Sponsor: Hoffmann-La Roche
- || Trial primary completion date: Counteracting Age-related Loss of Skeletal Muscle Mass (CALM) (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=68, Recruiting, Sponsor: Bispebjerg Hospital
N=51 --> 22 Trial primary completion date: Feb 2017 --> Feb 2018
- || Trial primary completion date: Counteracting Age-related Loss of Skeletal Muscle Mass (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=205, Recruiting, Sponsor: Bispebjerg Hospital
Trial primary completion date: Feb 2017 --> Feb 2018 Trial primary completion date: Feb 2017 --> Feb 2018
- Enrollment closed: Effect of Strength Training and Protein Ingestion in Old Versus Very-old (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=45, Active, not recruiting, Sponsor: Bispebjerg Hospital
Trial primary completion date: Feb 2017 --> Feb 2018 Recruiting --> Active, not recruiting
- Trial initiation date: Glucose Metabolism, Muscle Mass/Function and Inflammation in the Elderly (clinicaltrials.gov) - Jan 28, 2016
P=N/A, N=76, Not yet recruiting, Sponsor: Catholic University of the Sacred Heart
Recruiting --> Active, not recruiting Initiation date: Sep 2015 --> Mar 2016
- New trial: Prevalence of Sarcopenia and Its Geriatric Features (clinicaltrials.gov) - Jan 27, 2016
P=N/A, N=50, Recruiting, Sponsor: Brugmann University Hospital
- Trial completion: MaSS - Maastricht Sarcopenia Study (clinicaltrials.gov) - Jan 20, 2016
P=N/A, N=247, Completed, Sponsor: Maastricht University Medical Center
Initiation date: Sep 2015 --> Mar 2016 Active, not recruiting --> Completed
- Trial initiation date, Trial suspension, Trial primary completion date: Exercise and Branched Chain Amino Acids (BCAA)Requirements in Older Men (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=6, Suspended, Sponsor: University of Western Ontario, Canada
Active, not recruiting --> Completed Initiation date: Oct 2013 --> Jan 2016 | Not yet recruiting --> Suspended | Trial primary completion date: Oct 2014 --> Dec 2016
- Trial completion: The Benefits of Hemp Protein Supplementation During Resistance Training (clinicaltrials.gov) - Jan 6, 2016
P=N/A, N=34, Completed, Sponsor: University of Saskatchewan
Initiation date: Oct 2013 --> Jan 2016 | Not yet recruiting --> Suspended | Trial primary completion date: Oct 2014 --> Dec 2016 Recruiting --> Completed
- Enrollment open: ARMS-II: Detection and Treatment of Sarcopenia and Myosteatosis in Older African Americans (clinicaltrials.gov) - Jan 5, 2016
P=N/A, N=140, Recruiting, Sponsor: Washington D.C. Veterans Affairs Medical Center
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed, Trial primary completion date: Screening for Age-Related Skeletal Muscle Dysfunction (clinicaltrials.gov) - Jan 5, 2016
P=N/A, N=30, Active, not recruiting, Sponsor: Washington D.C. Veterans Affairs Medical Center
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Jun 2016
- Enrollment closed, Enrollment change: POWR-UP: A High Protein Weight Loss Intervention for Sarcopenic Obesity in Women (clinicaltrials.gov) - Jan 5, 2016
P=N/A, N=80, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Jun 2016 Recruiting --> Active, not recruiting | N=60 --> 80
- Enrollment change: Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults (clinicaltrials.gov) - Dec 29, 2015
P=N/A, N=75, Active, not recruiting, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting | N=60 --> 80 N=60 --> 75
- Biomarker, New trial: HAPPY: A Prospective Cohort Study of Aged People for Chronic Diseases (clinicaltrials.gov) - Dec 29, 2015
P=N/A, N=1000, Recruiting, Sponsor: Seoul National University Bundang Hospital
- New trial: Feasibility and Benefits of Group Based Exercise in Residential Aged Care Adults (clinicaltrials.gov) - Dec 29, 2015
P=N/A, N=37, Completed, Sponsor: Bond University
- Phase classification: Omega-3 Fatty Acids to Combat Sarcopenia (clinicaltrials.gov) - Dec 25, 2015
P1, N=24, Completed, Sponsor: Mayo Clinic
N=60 --> 75 Phase classification: P=N/A --> P1
- New trial: Role of MicroRNAs on Age and Contraction-induced Skeletal Muscle Growth (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=30, Recruiting, Sponsor: Tufts University
- Enrollment change, Trial termination: Effects of Fish or Meat Consumption in Elderly (clinicaltrials.gov) - Dec 14, 2015
P=N/A, N=14, Terminated, Sponsor: University of Bergen
Phase classification: P=N/A --> P1 N=200 --> 14 | Recruiting --> Terminated; Not enough patients to recruite.
- || bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly
Trial primary completion date: Dose Range Finding Study of Bimagrumab in Sarcopenia (clinicaltrials.gov) - Dec 11, 2015
P2, N=280, Recruiting, Sponsor: Novartis Pharmaceuticals
N=200 --> 14 | Recruiting --> Terminated; Not enough patients to recruite. Trial primary completion date: Dec 2016 --> Aug 2017
- New trial: RESTORE-ME: Effects of a Resistance Training Program in Older Women With Sarcopenia (clinicaltrials.gov) - Dec 11, 2015
P=N/A, N=25, Active, not recruiting, Sponsor: University of Rhode Island
- Trial primary completion date: Modulation of Muscle Protein Synthesis With Diet and Exercise in Old Aged Women (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=48, Recruiting, Sponsor: University of Nottingham
Trial primary completion date: Dec 2016 --> Aug 2017 Trial primary completion date: Aug 2015 --> Jan 2016
- Novolin R (recombinant human insulin) / Novo Nordisk
Enrollment status, Trial primary completion date: Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=32, Enrolling by invitation, Sponsor: University of Nottingham
Trial primary completion date: Aug 2015 --> Jan 2016 Recruiting --> Enrolling by invitation | Trial primary completion date: Nov 2015 --> Jun 2016
- Trial completion, Enrollment change, Trial primary completion date: Exercise Intermittent Isometric Handgrip and Blood Flow Restriction (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=18, Completed, Sponsor: Universidade Federal de Pernambuco
Recruiting --> Enrolling by invitation | Trial primary completion date: Nov 2015 --> Jun 2016 Recruiting --> Completed | N=15 --> 18 | Trial primary completion date: Aug 2015 --> Dec 2015
- Trial initiation date: Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men (clinicaltrials.gov) - Dec 5, 2015
P4, N=50, Recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Recruiting --> Completed | N=15 --> 18 | Trial primary completion date: Aug 2015 --> Dec 2015 Initiation date: Aug 2009 --> Mar 2009
- Enrollment closed, Enrollment change, Trial primary completion date: IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Initiation date: Aug 2009 --> Mar 2009 Recruiting --> Active, not recruiting | N=30 --> 40 | Trial primary completion date: Sep 2015 --> Jan 2016
- New trial: Omega-3 Supplementation and Resistance Training (clinicaltrials.gov) - Dec 2, 2015
P=N/A, N=20, Recruiting, Sponsor: University of Manitoba
- New trial, Surgery: ERAS in Colorectal Surgery Diminishes the Negative Impact of Sarcopenia on Short Term Outcomes (clinicaltrials.gov) - Dec 2, 2015
P=N/A, N=171, Completed, Sponsor: Jagiellonian University
- Enrollment change, Trial termination, Adverse events: BCS2: Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients (clinicaltrials.gov) - Nov 27, 2015
P=N/A, N=5, Terminated, Sponsor: Baltimore VA Medical Center
Recruiting --> Active, not recruiting | N=30 --> 40 | Trial primary completion date: Sep 2015 --> Jan 2016 N=40 --> 5 | Recruiting --> Terminated; The study was stopped due to recruitment difficulties
- valsartan / Generic mfg.
New P2 trial: Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients (clinicaltrials.gov) - Nov 17, 2015
P2, N=40, Recruiting, Sponsor: Wake Forest School of Medicine
- Trial completion, Enrollment change: Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults (clinicaltrials.gov) - Nov 10, 2015
P=N/A, N=48, Completed, Sponsor: Purdue University
N=40 --> 5 | Recruiting --> Terminated; The study was stopped due to recruitment difficulties Recruiting --> Completed | N=70 --> 48
- | Trial completion: Effect of Ursolic Acid of Loquat Extract on Function of Muscle (clinicaltrials.gov) - Nov 3, 2015
P2/3, N=54, Completed, Sponsor: Pusan National University Hospital
Recruiting --> Completed | N=70 --> 48 Active, not recruiting --> Completed
- New P3 trial: Effect of Vitamin D3 Supplementation on Muscle Mass in ICU Patient (clinicaltrials.gov) - Nov 3, 2015
P3, N=40, Not yet recruiting, Sponsor: Mahidol University
- Trial completion: Sarcopenia and Cirrhosis (clinicaltrials.gov) - Oct 29, 2015
P=N/A, N=17, Completed, Sponsor: Rigshospitalet, Denmark
Active, not recruiting --> Completed Recruiting --> Completed
- Trial primary completion date, PARP Biomarker: Skeletal Muscle Apoptosis and Physical Performance; Oxidative RNA/DNA Damage and Repair in Aged Human Muscle (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=63, Active, not recruiting, Sponsor: University of Florida
Recruiting --> Completed Trial primary completion date: Sep 2015 --> Oct 2016
- Enrollment closed: Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=10, Active, not recruiting, Sponsor: University of Florida
Trial primary completion date: Sep 2015 --> Oct 2016 Recruiting --> Active, not recruiting